WHO ICTRP trial

Evaluation of the efficacy of behavioral remodeling for treatment of resistant…

IRCT2017031112823N4 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting

Key facts

Trial ID IRCT2017031112823N4
Public title Evaluation of the efficacy of behavioral remodeling for treatment of resistant pes anserine tendino-bursitis
Scientific title Evaluation of the efficacy of behavioral remodeling for treatment of resistant pes anserine tendino-bursitis
Primary sponsor Semnan University of Medical Sciences, Vice Chancellor for Research and Technology
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Not Recruiting
Study type interventional
Countries Iran (Islamic Republic of)
Conditions Pes anserine bursitis. Other bursitis of knee;Other bursitis of knee
Interventions Intervention 1: In intervention group, in addition to receive naproxen (500 mg q 12 hrs) or diclofenac (75 mg per day) and pantoprazole (40 mg per day) for 2 weeks, weight loss, avoid to kneeling down and sitting crossed leg, quadriceps…
Registration date Aug 22, 2017
Target size 60
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations